0001836562-23-000001.txt : 20230602 0001836562-23-000001.hdr.sgml : 20230602 20230602170250 ACCESSION NUMBER: 0001836562-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230602 DATE AS OF CHANGE: 20230602 EFFECTIVENESS DATE: 20230602 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Hopewell Therapeutics, Inc. CENTRAL INDEX KEY: 0001836562 IRS NUMBER: 823045662 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-483254 FILM NUMBER: 23989961 BUSINESS ADDRESS: STREET 1: 405 WALTHAM STREET CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 617 921 7082 MAIL ADDRESS: STREET 1: 405 WALTHAM STREET CITY: LEXINGTON STATE: MA ZIP: 02421 D 1 primary_doc.xml X0708 D LIVE 0001836562 Hopewell Therapeutics, Inc. 301 West Cummings Park Woburn MA MASSACHUSETTS 01801 617 921 7082 DELAWARE None None Corporation true 2018 Thomas Hennessey c/o Hopewell Therapeutics, Inc. 310 West Cummings Park Woburn MA MASSACHUSETTS 01801 Executive Officer Director Thomas Hennessey c/o Hopewell Therapeutics, Inc. 310 West Cummings Park Woburn MA MASSACHUSETTS 01801 Director Xutian Jing c/o Hopewell Therapeutics, Inc. 310 West Cummings Park Woburn MA MASSACHUSETTS 01801 Director Howard Rosen c/o Hopewell Therapeutics, Inc. 310 West Cummings Park Woburn MA MASSACHUSETTS 01801 Director Jake Xia c/o Hopewell Therapeutics, Inc. 310 West Cummings Park Woburn MA MASSACHUSETTS 01801 Director Qiaobing Xu c/o Hopewell Therapeutics, Inc. 310 West Cummings Park Woburn MA MASSACHUSETTS 01801 Executive Officer Director Biotechnology Decline to Disclose 06b false 2023-05-19 false true false 0 10000001 3000002 6999999 false 1 0 0 0 false Hopewell Therapeutics, Inc. /s/ Louis Brenner Louis Brenner President and CEO 2023-06-02